Course Content

What is Nanomedicine?

Nanomedicine is the application of Nanotechnology (materials with sizes in the nanometre range, i.e. 10-9 m) to promote innovation in Healthcare. Nanomedicine is a revolutionary interdisciplinary science, which combines knowledge from Pharmacy, Physics, Biology, Chemistry and Medicine to treat conditions and diseases of the human body at a molecular level. Nanomedicine has many applications, from drug therapy and diagnostics to individual cell repair, to artificial tissues and radiation therapy. The NANOMED EMJMD is focusing on the Drug Delivery applications of Nanomedicine.

What is an EMJMD?

Erasmus Mundus Joint Master Degrees (EMJMDs) are highly integrated study programmes that are delivered by an international Consortium of Higher Education Institutions. They aim at fostering excellence, innovation, and internationalisation in Higher Education Institutions. EMJMDs are supported by the EACEA (Education, Audiovisual and Culture Executive Agency) of the European Commission and are part of the Erasmus + programme.

You can participate to an EMJMD as a scholarship student or as a self-funded student. To learn more about the application procedure please click here.

Course content

The NANOMED EMJMD is a Master programme exclusively taught in English that spreads over 23 months. It offers high quality education in the emerging field of Nanomedicine with a strong emphasis on multidisciplinarity. Designing nanomedicines for drug delivery requires to combine knowledge from various fields such as Pharmacy, Biology, Chemistry, Medicine, Physics or Engineering, which is why our Master programme value students from different backgrounds. The NANOMED EMJMD provides both theoretical and practical knowledge for 3 semesters (Semesters 1, 2 and 3, 30 ECTS each) combined with a final internship (Semester 4, 30 ECTS).

Semester 1

Semester 1 (from September to January) will be dedicated to the “Introduction to pharmaceutical formulation: from classical forms to nanoparticles”. Training will either take place in Patras or in Paris and will concern the Basis of Pharmaceutical Technology, i.e. Biopharmacy aspects, formulation, production as well as the related controls. This first step provides the essential knowledge necessary to work in Pharmaceutical domains and to introduce innovative drug delivery systems as used in Nanomedicine.

At the very beginning of semester 1 (September), an introductory module will be offered to non-pharmacy students with a background in chemistry or biology. Considering that some specific knowledge in both domains is required to efficiently design and develop pharmaceutical forms and in particular Nanomedicines, basic courses on biology will be provided to Chemists and chemistry courses to Biologists.

Semester 2

Semester 2 courses (from February to March) will be held in Paris and will cover “Basic Nanomedicine and Advanced Biology”. The Basic Nanomedicine module is dedicated to the design of nanovectors for various administration routes as well as their subsequent characterization and evaluation (theoretical and practical courses). The Advanced Biology module concerns the study of biological and biotechnological medicinal products. A 3-month internernship in the Consortium labs (Angers, Paris, Patras or Pavia) or at an Associated Partner’s lab will conclude this second semester (from April to June).

Each student will share a common background in Drug Delivery, by then, and will have had a serious introduction to Nanomedicine.

A two-weeks Summer School is organized at the end of semester 2 (July) in one of the four universities of the NANOMED Consortium to give students the opportunity to benefit from high quality conferences of an Invited Professor. During the Summer School students will also be in charge of organizing and participating in a two-days-long workshop. This workshop will give NANOMED students from first and second year as well as local PhD students the opportunity to present their research projects (oral and poster communications will be organized).

Semester 3

Semester 3 (from September to December) will be dedicated to the Advanced Nanomedicine part of the curriculum. It corresponds to the specialization of students by choosing a training option according to their professional project.

In Angers, “Strategy of Nanomedicine Development for Clinical Application” is training professionals to manage innovative research project with skills in pharmaceutical development (Quality by Design) and non-clinical development of Nanomedicine.

In Pavia, the training will be dedicated to the “Production and Biotechnology applications of Nanomedicine” providing students with in-depth knowledge on different biotech applications, regulation and production.

Semester 4

During the final internship period (Semester 4, 6 months from January to June), students will apply this new knowledge to the successful achievement of research and development projects on Nanomedicine in either an academic team or selected private companies.

During the two-day-long workshop held in July, 2nd year students will defend their Master thesis in front of an international jury composed of external experts and NANOMED Professors.

Back to Top